CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Operating activities:
Net income attributable to common shareholders	$ 219,502	$ 216,993	$ 26,315
Noncontrolling interest in subsidiaries' earnings	1,449	828	201
Net income before allocation to noncontrolling interests	220,951	217,821	26,516
Asbestos Provision	0	0	241,647
Environmental charge	0	0	30,327
Gain on divestiture	(2,727)	(29,445)	(4,258)
Restructuring - Non Cash	0	3,855	0
Depreciation and amortization	54,837	57,263	62,943
Stock-based compensation expense	22,791	17,319	14,972
Defined benefit plans and postretirement expense	4,779	20,090	6,770
Deferred income taxes	48,964	55,000	(43,923)
Cash provided by (used for) operating working capital	(26,672)	1,824	(41,955)
Defined benefit plans and postretirement contributions	(15,929)	(5,504)	(48,113)
Environmental payments, net of reimbursements	15,403	13,371	9,534
Payments for asbestos-related fees and costs, net of insurance recoveries	(62,827)	(77,957)	(79,277)
Other	(10,668)	12,139	6,303
Total provided by operating activities	239,432	234,756	149,812
Investing activities:
Capital expenditures	(29,461)	(29,308)	(34,737)
Proceeds from disposition of capital assets	455	6,438	4,793
Payment for acquisition, net of cash acquired	(801,781)	0	(36,590)
Proceeds from divestiture	6,836	54,079	1,000
Total (used for) provided by investing activities	(823,951)	31,209	(65,534)
Equity:
Dividends paid	(67,272)	(61,974)	(56,992)
Reacquisition of shares on open market	0	(49,991)	(79,999)
Stock options exercised - net of shares reacquired	24,922	13,056	23,232
Excess tax benefit from stock-based compensation	6,353	3,603	6,097
Proceeds from Lines of Credit	125,000	0	0
Debt:
Proceeds received from issuance of long-term notes	(321)	0	(1,003)
Proceeds from Issuance of Long-term Debt	550,000	0	0
Payments of Debt Issuance Costs	(6,006)	0	0
Repayments of Long-term Debt	(200,000)	0	0
Total provided by (used for) financing activities	432,676	(95,306)	(108,665)
Effect of exchange rates on cash and cash equivalents	(1,461)	8,199	(3,465)
Increase (decrease) in cash and cash equivalents	(153,304)	178,858	(27,852)
Cash and cash equivalents at beginning of period	423,947	245,089	272,941
Cash and cash equivalents at end of period	270,643	423,947	245,089
Detail of cash used for working capital:
Accounts receivable	(42,857)	(2,578)	(44,120)
Inventories	28,116	8,551	(38,407)
Other current assets	2,977	(1,656)	2,549
Accounts payable	17,962	(11,724)	35,129
Accrued liabilities	(28,924)	(5,830)	(3,315)
U.S. and foreign taxes on income	(3,946)	15,061	6,209
Total	(26,672)	1,824	(41,955)
Supplemental disclosure of cash flow information:
Interest paid	28,164	26,690	26,158
Income taxes paid	$ 53,695	$ 26,270	$ 25,555